Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Search results

Found 11 matches for

The University of Oxford has entered into a strategic collaboration with Janssen Biotech, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson.

Close up of hand pipetting in lab © Medical Sciences Division and John Cairns

MANTIS

Botnar Hip

Managing Avascular Necrosis Treatments : An Interventional Study

WHITE-5

Botnar Hip

FAIT

Botnar Hip

FAIT is a multicentre randomised controlled clinical trial comparing surgical and non-surgical approaches to treating femoroacetabular impingement (hip impingement).

WHITE-4

Botnar Hip

World Hip Trauma Evaluation Four

Glyn-Jones Group | Hip Research Group

Botnar Hip

Our research focuses on hip osteoarthritis, from identifying its causes to developing new surgery techniques for the condition.

Find out more about

Our Groups, Centres and Units

Our Research Themes

Our Clinical Trials

Our Programme Grants

Similar stories

Doctor Ghada Alsaleh awarded a Versus Arthritis Career Development Fellowship

Postdoctoral Researcher Ghada Alsaleh has been awarded a research grant by Versus Arthritis which she will use to develop a new therapy for osteoarthritis.

Study finds marked differences in the use of ankle replacements across six countries

A new study published in Foot and Ankle International reviews the use of ankle replacements across 6 countries to predict why there is a variance in their use, and to determine how far current demands are being met.

NDORMS wins government funding to develop AI for bone health

A state-of-the-art method that uses artificial intelligence to check bone health and reduce fracture risk has been successful in the latest round of the Artificial Intelligence in Health and Care Award.

COVID-19 vaccine safety monitoring should account for age, gender, and database differences

The largest, most extensive global network study on background rates for adverse events of special interest identifies important age, sex and database differences that should inform future safety surveillance efforts.

Professor Keith Willett recognised in Queen’s Birthday Honours

Professor of Orthopaedic Trauma Surgery at NDORMS, Keith Willett becomes a Knight Bachelor for services to the NHS.

Professor Dani Prieto-Alhambra elected to ISPE Board of Directors

Dani Prieto-Alhambra, Professor of Pharmaco- and Device Epidemiology at NDORMS, has been elected as the Academic representative for Europe and Africa on the International Society of Pharmaco-Epidemiology Board of Directors.